Trans1, a medical device company focused on designing, developing and marketing products to treat degenerative disc disease affecting the lower lumbar region of the spine, filed for an IPO Tuesday with the SEC. The company filed to be listed on the NASDAQ with the ticker "TSON." Lehman Brothers and Piper Jaffray are the lead managers on the deal. No terms were disclosed in the initial filing.
